default author photo

Heather-Marie Schmidt

World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme

Geneva

Switzerland

  • World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme

SCHOLARLY PAPERS

2

DOWNLOADS

220

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Balancing Accuracy, Accessibility, and Cost: HIV Testing Strategies for Long-Acting Injectable Pre-Exposure Prophylaxis: A Systematic Review of Rapid, Laboratory-Based Immunoassay and Nucleic Acid Testing Strategies

Number of pages: 21 Posted: 04 Jun 2025
Warittha Tieosapjaroen, Eloise Williams, Cheryl Johnson, Carlota Almeida Baptista da Silva, Magdalena Barr-DiChiara, Michelle Rodolph, Heather Leigh Ingold, Heather-Marie Schmidt, Mateo Prochazka, Busisiwe Msimanga Radebe, Céline Lastrucci, Hortencia Peralta, Lastone Chitembo, Precious Andifasi, Nandi Siegfried, Raphael Landovitz and Jason J. Ong
Alfred Health - Melbourne Sexual Health Centre, University of Melbourne - Department of Microbiology, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, Independent, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, World Health Organization (WHO), World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, Pan American Health Organization, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, South African Medical Research Council - Health Systems Research Unit, University of California, Los Angeles (UCLA) - UCLA Center for Clinical AIDS Research and Education and Alfred Health
Downloads 124 (580,653)

Abstract:

Loading...

injectable pre-exposure prophylaxis, cabotegavir, lenacapavir, HIV testing, rapid diagnostic test, nucleic acid test, point-of-care test, HIV self-testing

2.

Global Adoption of Guidelines on and Use of Oral Pre-Exposure Prophylaxis (PrEP): Current Situation and Future Projections

Number of pages: 16 Posted: 01 Mar 2021
Robin Schaefer, Heather-Marie Schmidt, Giovanni Ravasi, Antons Mozalevskis, Bharat B. Rewari, Frank Lule, Kouadio Yeboue, Anne Brink, Nabeel Mangadan Konath, Mukta Sharma, Nicole Seguy, Joumana Hermez, Ahmed Sabry Alaama, Naoko Ishikawa, Boniface Dongmo Nguimfack, Daniel Low-Beer, Rachel Baggaley and Shona Dalal
World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, Pan American Health Organization, World Health Organization (WHO) - Regional Office for Europe, World Health Organization (WHO) - Regional Office for South-East Asia, World Health Organization (WHO) - Regional Office for Africa, World Health Organization (WHO) - Regional Office for Africa, World Health Organization (WHO) - Regional Office for the Western Pacific, World Health Organization (WHO) - Regional Office for South-East Asia, World Health Organization (WHO) - Regional Office for South-East Asia, World Health Organization (WHO) - Regional Office for Europe, World Health Organization (WHO) - Regional Office for the Eastern Mediterranean, World Health Organization (WHO) - Regional Office for the Eastern Mediterranean, World Health Organization (WHO) - Regional Office for the Western Pacific, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme, World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme and World Health Organization (WHO) - Global HIV, Hepatitis and STI Programme
Downloads 96 (709,832)

Abstract:

Loading...